Neuropsychiatric Disorders in Cushing's Syndrome

被引:109
作者
Pereira, Alberto M. [1 ]
Tiemensma, Jitske [1 ]
Romijn, Johannes A. [1 ]
机构
[1] Leiden Univ, Med Ctr, Dept Endocrinol & Metab Dis, NL-2333 ZA Leiden, Netherlands
关键词
Cushing's syndrome; Treatment; Depression; Mania; Psychopathology; QUALITY-OF-LIFE; PITUITARY-ADENOMAS; DISEASE; PERSONALITY; CORTISOL; PSYCHOPATHOLOGY; MANIFESTATIONS; DEPRESSION; CURE;
D O I
10.1159/000314317
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucocorticoids are crucial in the initiation and consolidation of the stress response. Patients with active Cushing's syndrome (CS) are exposed to excessive endogenous glucocorticoid levels. In these patients, psychopathology is often being observed. The most common co-morbid disorder is major depression, but to a lesser extent mania and anxiety disorders have also been reported. A severe clinical presentation of CS often also includes depression. Reduction of glucocorticoid synthesis or action, either with metyrapone, ketoconazole, or mifepristone, rather than treatment with antidepressant drugs, is generally successful in relieving depressive symptoms, as well as other disabling symptoms. Following successful surgical treatment of hypercortisolism, both physical and psychiatric signs and symptoms improve substantially. However, it appears that patients do not completely return to their premorbid level of functioning and persistent impairment of quality of life and cognitive function has been reported despite long-term cure. At present, it is not clear whether, and to which extent, psychopathology still affects general well-being after long-term cure of CS. Copyright (C) 2010 S. Karger AG, Basel
引用
收藏
页码:65 / 70
页数:6
相关论文
共 50 条
  • [21] Long-term cognitive effects of glucocorticoid excess in Cushing's syndrome
    Forget, Helene
    Lacroix, Andre
    Bourdeau, Isabelle
    Cohen, Henri
    PSYCHONEUROENDOCRINOLOGY, 2016, 65 : 26 - 33
  • [22] Neuropsychiatric Findings in Cushing Syndrome and Exogenous Glucocorticoid Administration
    Starkman, Monica N.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2013, 42 (03) : 477 - +
  • [23] Adrenal Cushing's syndrome may resemble eating disorders
    Hatakeyama, Makiko
    Nakagami, Taku
    Yasui-Furukori, Norio
    GENERAL HOSPITAL PSYCHIATRY, 2014, 36 (06) : 760.e9 - 760.e10
  • [24] Neuropsychological and Emotional Functioning in Patients with Cushing's Syndrome
    Na, Sabrina
    Fernandes, Mary A.
    Ioachimescu, Adriana G.
    Penna, Suzanne
    BEHAVIOURAL NEUROLOGY, 2020, 2020
  • [25] A clinical index for rating severity in Cushing's syndrome
    Sonino, N
    Boscaro, M
    Fallo, F
    Fava, GA
    PSYCHOTHERAPY AND PSYCHOSOMATICS, 2000, 69 (04) : 216 - 220
  • [26] Mifepristone for Management of Cushing's Syndrome
    Morgan, Farah H.
    Laufgraben, Marc J.
    PHARMACOTHERAPY, 2013, 33 (03): : 319 - 329
  • [27] THERAPEUTIC TARGETS FOR CUSHING'S SYNDROME
    Brown, A. E.
    Sorbera, L. A.
    Dulsat, C.
    Rosa, E.
    DRUGS OF THE FUTURE, 2012, 37 (12) : 855 - 862
  • [28] Pregnancy in Patients with Cushing's Syndrome
    Machado, Marcio Carlos
    Barisson Vilares Fragoso, Maria Candida
    Bronstein, Marcello Delano
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2018, 47 (02) : 441 - +
  • [29] Diagnostic workup of Cushing's syndrome
    Balomenaki, Maria
    Margaritopoulos, Dimitris
    Vassiliadi, Dimitra Argyro
    Tsagarakis, Stylianos
    JOURNAL OF NEUROENDOCRINOLOGY, 2022, 34 (08)
  • [30] Systemic therapy of Cushing's syndrome
    Eckstein, Niels
    Haas, Bodo
    Hass, Moritz David Sebastian
    Pfeifer, Vladlena
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9